Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kidron Capital Assets LP is a venture capital firm founded in 2021 by Anula Jayasuriya and Maria Gajda Horowitz. The firm operates from its bases in the United States and Israel, focusing exclusively on women's health. Kidron Capital aims to address unmet medical needs through investments in various technologies and business models that enhance health outcomes for female patients.
Currently, Kidron Capital manages a portfolio of five companies and is actively deploying capital into early-stage opportunities. The firm emphasizes a scientific and regulatory approach to investment, ensuring that the technologies they support are compliant with industry standards and protected by patents. This strategy positions their portfolio companies for success in the competitive healthcare market.
Kidron Capital has garnered attention in the femtech sector, being recognized by various industry publications and networks. Their commitment to improving women's health outcomes is reflected in their investment philosophy, which seeks to identify and support innovations that can significantly impact the quality of care and patient experience.
Kidron Capital invests in early-stage opportunities within women's health, targeting a range of modalities including medical devices, diagnostics, therapeutics, digital health, healthcare services, and consumer solutions. The firm emphasizes a holistic investment strategy that prioritizes technologies meeting regulatory standards and possessing patent protection. This focus ensures that their investments are not only innovative but also viable in the market.
The geographical scope of Kidron Capital's investments includes the United States, Europe, and Israel, allowing them to tap into diverse markets and healthcare systems. Their investment thesis centers on addressing unmet medical needs that disproportionately affect women, such as conditions related to reproductive health, maternal health, and chronic diseases. Kidron Capital seeks to partner with founders who are committed to making a difference in women's health and who demonstrate a strong understanding of their target markets.
Kidron Capital's portfolio consists of five notable companies, each addressing critical issues in women's health:
These companies exemplify Kidron Capital's commitment to investing in innovative solutions that address the unique health challenges faced by women.
Anula Jayasuriya: Co-founding Managing Partner at Kidron Capital, Anula holds an MD, PhD, and MBA from Harvard. She has a deep background in HealthTech investments and has been instrumental in shaping the firm's focus on women's health.
Maria Gajda Horowitz: Co-founding Managing Partner, Maria brings extensive experience in venture capital and a strong commitment to advancing women's health. Her leadership at Kidron Capital is pivotal in identifying and supporting innovative health solutions.
To pitch to Kidron Capital, founders should send an email to info@kidron-capital.com. A well-structured pitch deck is essential, including details about the business model, market analysis, and team qualifications. Kidron Capital appreciates concise presentations that clearly outline the problem being addressed and the proposed solution.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In April 2024, Kidron Capital announced the first close of its women's health venture capital fund, marking a significant milestone for the firm. This close has attracted attention from various industry publications, highlighting Kidron's commitment to investing in early-stage opportunities within women's health.
The firm has been actively deploying capital into US-based portfolio companies, focusing on technologies that address critical issues in women's health. Recent investments include projects aimed at improving chemotherapy access and developing solutions for polycystic ovary syndrome (PCOS).
What are Kidron Capital's investment criteria?
Kidron Capital focuses on early-stage investments in women's health, targeting technologies that address unmet medical needs. They prioritize innovations that comply with regulatory standards and are protected by patents.
How can I apply or pitch to Kidron Capital?
Founders can reach out to Kidron Capital via email at info@kidron-capital.com to discuss potential investment opportunities. A detailed pitch deck outlining the business model, market potential, and team background is recommended.
What makes Kidron Capital different from other venture firms?
Kidron Capital exclusively focuses on women's health, investing in technologies that address specific health challenges faced by female patients. Their deep expertise in this sector allows them to provide tailored support to portfolio companies.
What is the geographical scope of Kidron Capital's investments?
Kidron Capital invests primarily in the United States, Europe, and Israel, allowing them to tap into diverse healthcare markets and regulatory environments.
What is Kidron Capital's approach to post-investment involvement?
Kidron Capital actively supports its portfolio companies by leveraging its industry connections and expertise in women's health. They focus on helping companies navigate regulatory challenges and enhance their market positioning.
What is the typical check size for investments made by Kidron Capital?
While specific check sizes are not disclosed, Kidron Capital targets early-stage investments, indicating a focus on seed and Series A funding rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.